Dr. Sulaiman Al Habib Medical Services Group Beheer
Beheer criteriumcontroles 4/4
De CEO Dr. Sulaiman Al Habib Medical Services Group is Faisal Abdullah Al Nassar, benoemd in Jan2011, heeft een ambtstermijn van 13.83 jaar. bezit rechtstreeks 0% van de aandelen van het bedrijf, ter waarde SAR 275.47K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.8 jaar en 5.9 jaar.
Belangrijke informatie
Faisal Abdullah Al Nassar
Algemeen directeur
ر.س230.0k
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 13.8yrs |
| Eigendom CEO | 0.0003% |
| Management gemiddelde ambtstermijn | 5.8yrs |
| Gemiddelde ambtstermijn bestuur | 5.9yrs |
Recente managementupdates
Recent updates
Solid Earnings May Not Tell The Whole Story For Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 11
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Paying Out A Larger Dividend Than Last Year
Nov 07Dr. Sulaiman Al Habib Medical Services Group Company Just Recorded A 9.6% Revenue Beat: Here's What Analysts Think
Nov 06Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Ticks All The Boxes When It Comes To Earnings Growth
Oct 17Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27CEO
Faisal Abdullah Al Nassar (44 yo)
13.8yrs
Tenure
ر.س230,000
Compensatie
Mr. Faisal Abdullah Ali Al Nassar is Non-Executive Director of Tamkeen Human Resources Company from 2022. Mr. Al Nassar serves as a Non-Executive Independent Deputy Chairman of the Board at Al Ramz Real Es...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Group Founder & Non-Executive Chairman | 5.9yrs | ر.س172.00k | 40.03% SAR 38.0b | |
| Group CFO | 13.8yrs | ر.س230.00k | 0.00029% SAR 275.5k | |
| Chief of Business Development & Strategy and Executive Director | no data | ر.س230.00k | 2% SAR 1.9b | |
| Chief Operating Officer | no data | geen gegevens | 0.0095% SAR 9.1m | |
| Group General Counsel & Secretary of the Board | 8.8yrs | geen gegevens | geen gegevens | |
| Chief People Officer | no data | geen gegevens | geen gegevens | |
| Head of Internal Audit Department | 8.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Medical Affairs | 2.8yrs | geen gegevens | 0.041% SAR 38.7m | |
| Senior Vice President of Physicians Affairs | 2.8yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer | 2.7yrs | geen gegevens | geen gegevens | |
| General Director of Pharmaceutical Facilities | no data | geen gegevens | geen gegevens | |
| CEO and Member of the Board of Managers of Hulool Al Sahabah for IT & Communication Company | no data | geen gegevens | geen gegevens |
5.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van 4013 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Group Founder & Non-Executive Chairman | 5.9yrs | ر.س172.00k | 40.03% SAR 38.0b | |
| Group CFO | 5.9yrs | ر.س230.00k | 0.00029% SAR 275.5k | |
| Chief of Business Development & Strategy and Executive Director | 5.9yrs | ر.س230.00k | 2% SAR 1.9b | |
| CEO and Member of the Board of Managers of Hulool Al Sahabah for IT & Communication Company | no data | geen gegevens | geen gegevens | |
| Independent DIrector | 5.9yrs | ر.س178.00k | 0.0063% SAR 6.0m | |
| Independent Vice Chairman | 5.9yrs | ر.س230.00k | 0.023% SAR 21.9m | |
| Non-Executive Director | 5.9yrs | ر.س190.00k | geen gegevens | |
| Independent Director | no data | ر.س230.00k | 0% SAR 0 | |
| Independent Director | 2.9yrs | ر.س230.00k | 0.000030% SAR 28.5k |
5.9yrs
Gemiddelde duur
Ervaren bestuur: De raad van bestuur van 4013 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.9 jaar).